Stock WINT WINDTREE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Financials Windtree Therapeutics, Inc.

Equities

WINT

US97382D5014

Biotechnology & Medical Research

Market Closed - Nasdaq
Other stock markets
 21:30:01 01/05/2024 BST 		5-day change 1st Jan Change
4.49 USD -11.35% Intraday chart for Windtree Therapeutics, Inc. -12.90% -65.31%
04-16 Windtree Therapeutics, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 CI
04-11 North American Morning Briefing : Stock Futures -2- DJ

Valuation

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Capitalization 1 174.4 86.8 45.37 6.564 3.702 2.29 - -
Enterprise Value (EV) 1 174.4 86.8 45.37 6.564 3.702 2.29 2.29 2.29
P/E ratio -5.06 x -2.47 x -0.59 x -0.14 x -0.14 x -0.26 x -0.38 x -0.41 x
Yield - - - - - - - -
Capitalization / Revenue - - - - - - - -
EV / Revenue - - - - - - - -
EV / EBITDA - - - - - - - -
EV / FCF - -3.46 x -1.89 x - - -0.12 x -0.09 x -0.08 x
FCF Yield - -28.9% -52.8% - - -825% -1,170% -1,328%
Price to Book - - - - - - - -
Nbr of stocks (in thousands) 15.2 18.8 31.4 42.9 286 510 - -
Reference price 2 11,475 4,617 1,444 153.0 12.94 4.490 4.490 4.490
Announcement Date 03/04/20 29/03/21 31/03/22 03/04/23 16/04/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net sales 1 - - - - - - - -
EBITDA - - - - - - - -
EBIT 1 - -30.32 -77.28 - -20.6 -21.5 -29.6 -35.4
Operating Margin - - - - - - - -
Earnings before Tax (EBT) 1 - -32.57 -77.62 - -20.29 -21.6 -29.7 -35.5
Net income 1 -27.48 -32.57 -67.64 - -20.29 -21.6 -29.7 -35.5
Net margin - - - - - - - -
EPS 2 -2,268 -1,872 -2,457 -1,120 -94.32 -17.46 -11.88 -10.98
Free Cash Flow 1 - -25.07 -23.94 - - -18.9 -26.8 -30.4
FCF margin - - - - - - - -
FCF Conversion (EBITDA) - - - - - - - -
FCF Conversion (Net income) - - - - - - - -
Dividend per Share - - - - - - - -
Announcement Date 03/04/20 29/03/21 31/03/22 03/04/23 16/04/24 - - -
1USD in Million2USD
Estimates

Income Statement Evolution (Quarterly data)

Fiscal Period: December 2021 Q3 2021 Q4 2022 Q1 2022 Q2 2022 Q3 2022 Q4 2023 Q1 2023 Q2 2023 Q3 2023 Q4
Net sales 1 - - - - - - - - - -
EBITDA - - - - - - - - - -
EBIT 1 -8.147 -14.69 -8.333 -17.54 -4.65 - -4.191 -6.757 -4.69 -4.959
Operating Margin - - - - - - - - - -
Earnings before Tax (EBT) 1 -8.213 -14.73 -8.127 -17.33 -4.056 - -4.111 -6.601 -4.425 -5.154
Net income 1 -8.213 -13.07 -8.127 -17.33 -4.056 - -4.111 -6.601 -4.425 -5.154
Net margin - - - - - - - - - -
EPS 2 -279.0 -378.0 -261.0 -531.0 -117.0 -234.2 -85.68 -29.52 -15.48 -13.32
Dividend per Share - - - - - - - - - -
Announcement Date 10/11/21 31/03/22 05/05/22 11/08/22 14/11/22 03/04/23 15/05/23 07/08/23 09/11/23 16/04/24
1USD in Million2USD
Estimates

Balance Sheet Analysis

Fiscal Period: December 2019 2020 2021 2022 2023 2024 2025 2026
Net Debt - - - - - - - -
Net Cash position - - - - - - - -
Leverage (Debt/EBITDA) - - - - - - - -
Free Cash Flow 1 - -25.1 -23.9 - - -18.9 -26.8 -30.4
ROE (net income / shareholders' equity) - - - - - - - -
ROA (Net income/ Total Assets) - - - - - - - -
Assets 1 - - - - - - - -
Book Value Per Share - - - - - - - -
Cash Flow per Share - - - - - - - -
Capex - - 0.28 - - - - -
Capex / Sales - - - - - - - -
Announcement Date 03/04/20 29/03/21 31/03/22 03/04/23 16/04/24 - - -
1USD in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
1
Last Close Price
4.49 USD
Average target price
18 USD
Spread / Average Target
+300.89%
Consensus

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar

Sector Other Biotechnology & Medical Research

1st Jan change Capi.
WINDTREE THERAPEUTICS, INC. Stock Windtree Therapeutics, Inc.
-65.31% 2.29M
IQVIA HOLDINGS INC. Stock Iqvia Holdings Inc.
+0.67% 42.4B
LONZA GROUP AG Stock Lonza Group AG
+46.17% 40.04B
CELLTRION, INC. Stock Celltrion, Inc.
-6.20% 28.31B
ICON PUBLIC LIMITED COMPANY Stock ICON Public Limited Company
+6.55% 24.94B
ALNYLAM PHARMACEUTICALS, INC. Stock Alnylam Pharmaceuticals, Inc.
-21.66% 18.96B
MEDPACE HOLDINGS, INC. Stock Medpace Holdings, Inc.
+29.96% 12.3B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Stock Charles River Laboratories International, Inc.
-1.57% 11.95B
UNITED THERAPEUTICS CORPORATION Stock United Therapeutics Corporation
+16.03% 11.32B
BIO-TECHNE CORPORATION Stock Bio-Techne Corporation
-4.80% 11.55B
Other Biotechnology & Medical Research
  1. Stock Market
  2. Equities
  3. WINT Stock
  4. Financials Windtree Therapeutics, Inc.